Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12Cl2F3N7O2S |
| Formula Wt. | 506.30 |
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
http://clinicaltrials.gov/show/NCT01425008
Nedd8-activating enzyme inhibitor.
Wee1 inhibitor.
Thienylbutyl ITC analog.
Steroid 5-α-reductase inhibitor.
Imidazole; 14-α demethylase inhibitor.
Fermentation impurity
AMPA positive allosteric modulator, D2, 5-HT2A,...
Micronuclei formation inducer, antimitotic, oxi...
PDE3/5 inhibitor, LTD4 antagonist.
Coccidiostat, GAPDH inhibitor.
Phenyl hydrazide; neuronal oxidative stress inh...
SERT and NET inhibitor, Nav1.7 Na+ channel bloc...
Thienylbutyl ITC analog.
Glycylcycline; protein synthesis inhibitor.
Synthetic peptide; FPRL1 agonist.
Natural antibiotic found in Streptomyces parvul...
Prodrug
δ2OR antagonist.
Mycotoxin produced by species of Aspergillus; D...